Summary. The action of the potassium channel activator, cromakalim (BRL 34915), on membrane potential, input resistance and current-voltage-relationship of CA3 neurons in a slice preparation of the guinea-pig hippocampus was investigated by means of intracellular recordings. In the presence of tetrodotoxin, cromakalim (30-/00 gmol/1) produced a hyperpolarization up to 4 mV associated with a decrease in input resistance up to 10 MOhms. Determination of the equilibrium potential of the cromakalim action revealed that the hyperpolarization is due to the activation of a potassium conductance. This cromakalim-activated potassium conductance was voltage-dependent, i.e. it increased with hyperpolarization. Among a number of potassium channel blockers tested, only Cs + (2 mmol/1) and Ba 2+ (0.5 retool/l) were able to inhibit the cromakalim-induced effects. Simultaneously, both cations suppressed the hyperpolarizing inward rectification (anomalous rectification) in these neurons, indicating that cromakalim activated or potentiated an inwardly rectifying potassium conductance. In addition, cromakalim slightly enhanced both amplitude and duration of afterhyperpolarizations following single calcium-dependent action potentials, suggesting that cromakalim might have a weak facilitatory effect on calcium-dependent potassium conductances.
Introduction
The antihypertensive compound cromakalim (BRL 34915) has been shown to activate potassium channels in smooth muscle cells, thereby leading to a hyperpolarization of the membrane potential and to smooth muscle relaxation (Allen et al. 1986; Hamilton et al. 1986; Weir and Weston 1986; Coldwell and Howlett 1987; Nakao et al. •988) . With regard to the central nervous system, Alzheimer and ten Bruggencate (1988) demonstrated that in hippocampal slices cromakalim reduces epileptiform activity induced by changes in the ionic composition of the perfusion medium (elevation of K +, omission of Ca z+ or Mg2+). Also, at the same concentrations (30-100 gM), cromakalim inhibited synaptic transmission as indicated by a reduction in the amplitude of the stimulus-evoked population spike. In adSend offprint requests to C. Alzheimer at the above address dition, intracellular recordings from CA3 neurons revealed that the compound decreased the frequency of intrinsically generated spontaneous burst discharges which occur in these neurons under normal conditions (see Hablitz and Johnston 1981) . In particular, the latter observation led to the conclusion that cromakalim influences epileptiform activity by acting on intrinsic membrane conductances which control neuronal excitability (Alzheimer and ten Bruggencate 1988) . The anticonvulsive activity of cromakalim has been confirmed in vivo by showing that the drug prevents epileptiform seizures induced by the mast cell degranulating peptide (Gandolfo et al. 1989 ).
The present study was designed to investigate in more detail the effects of cromakalim on intrinsic membrane properties ofhippocampal CA3 pyramidal cells. Thus, the actions of cromakalim on membrane potential and current-voltagerelationships were studied in the presence of tetrodotoxin (TTX), i.e. in neurons functionally isolated from synaptic input. In addition, several potassium channel blockers were tested for their ability to abolish the effects of cromakalim.
Methods
Slices of the guinea-pig hippocampus were prepared and maintained as described previously (Alzheimer and ten Bruggencate 1988) . The artificial cerebrospinal fluid (ACSF) contained (in retool/l): NaC1 118, KC1 3, CaCI2 1.5, MgCI2 1, NaHzPO4 1.2, NaHCO3 22, D-glucose l 1. The solution was gassed continuously with a mixture consisting of 95% O2 and 5% CO2 in order to obtain a pH value of 7.4 at a temperature of 30-31 ° C. When CsC1 or tetraethylammonium chloride (TEA) were added to the ACSF, equimolar amounts of NaC1 were omitted from the solution.
Intracellular recordings from CA3 pyramidal neurons were performed by means of glass microelectrodes filled with either 3 tool/1 KC1 or 2 tool/1 CsC1. The electrode resistance ranged between 35 and 80 MOhms. Intracellular signals were recorded and amplified using an Axoclamp 2 amplifier (Axon Instruments, Burlingame, CA, USA) or, in more recent experiments, an npi SEC 1L amplifier (npi, Tamm, FRG). For current passage via the recording electrode both devices employ the discontinuous current injection technique ("switched current clamp"). Using the npi SEC 1L amplifier, single-electrode voltage-clamp recordings were performed at switching frequencies of 18-22 kHz (25% duty cycle). The adjustment of the amplifier and the criteria for the selection of microelectrodes have been described previously (Sutor and Zieglgfinsberger 1987) . Intracellular signals obtained in the course of current-and voltage-clamp measurements of I/V-relations were averaged on-line ( 4 -6 sweeps) and stored using a laboratory computer system (CED 1401, Cambridge Instruments, Cambridge, UK, in conjunction with a Tandon PCA 30). The membrane potential and the input resistance (RN, determined by injection of current pulses of 0.2 nA at a frequency of 0.1 -0 . 2 Hz) were continuously monitored on a chart recorder (Gould System Instruments, Cleveland, OH, USA) and stored on magnetic tape (TEAC MR30, Tokyo, Japan, frequency response of the tape recorder DC-2.5 kHz) for off-line analysis. The burst frequency of CA3 neurons was determined using a spike rate analyser. Action potentials were photographed directly from the screen of an analog storage oscilloscope (Tektronix, Beaverton, OR, USA) and hard copies of the digitised data were obtained with a HP 7470A plotter.
Cromakalim [( -t-)6 -cyano -3,4 -dihydro -2,2 -dimethyltrans-4 -(2 -oxo -1 -pyrrolidyl) -2 H -benzo[b]pyran -3 -ol] was kindly provided by Beecham-W/ilfing (Gronau, FRG). Stock solutions of cromakalim (30 mmol/1) were made up freshly in dimethyl sulfoxide (DMSO) and diluted in ACSF to reach final concentrations between 30 and 100 gmol/1. Final solvent concentrations were less than 0.33%. At this concentration, DMSO had no significant effects when applied in control experiments (n = 4).
CA3 pyramidal neurons were "isolated" from synaptic input by adding 0.6 gmol/1 TTX to the bathing solution. Potassium conductances were blocked by TEA ( 1 0 -15 retool/l), 4-amino pyridine (4-AP, 0.1 mmol/1), BaC12 (0.5 mmol/1), and CsC1 (2 mmol/1). In a few experiments, tolbutamide (0.5-1 mmol/1) was added to the ACSF in order to block putative ATP-sensitive potassium conductances. All drugs were obtained from Sigma (Taufkirchen, FRG). The substances were applied by addition to the bathing solution. The flow rate of the superfusion system was set to 4 -6 ml/min.
Values are given as mean ___ standard error of the mean (SEM). Statistical comparisons of mean values were performed using the paired Student's t-test.
Results
Intracellular recordings were obtained from 61 neurons. Under control conditions (i.e. in the absence of TTX), the cells were selected on the basis of their resting membrane potential (RMP > -6 0 mV), their input resistance (RN > 50 MOhms), and the overshoot of spontaneous or directly evoked action potentials (> 15 mV). In normal ACSF, the neurons usually displayed spontaneous activity consisting of either single action potentials or of small burst discharges, where two to four single spikes were present on top of a small depolarizing wave (see Johnston et al. 1980 and Johnston 1981) . The frequency of spontaneous discharges ranged between 0.5 and 4 Hz.
Effects of cromakalim on R M P and RN
Within 5 --8 min following superfusion with a TTX-containing medium, a complete cessation of spontaneous and synaptically evoked firing of CA3 neurons was observed. In the presence of TTX, addition of 100 ~tmol/1 cromakalim to the bathing solution consistently produced a hyperpolarization of the RMP by about 4 mV and a decrease in RN by Table 1 ). Both, the cromakaliminduced hyperpolarization and the reduction in RN were reversible following washout of the drug ( Fig. 1 A, Table 1 ). Under the experimental conditions used, the hyperpolarization started 5 -7 min after onset of drug application and reached its maximum after a further 1 0 -1 5 min. Upon washout of cromakalim, RMP and RN recovered within 1 5 -2 0 min, a time course similar to that observed in extracellular recordings (Alzheimer and ten Bruggencate 1988) . A paired t-test performed in 10 randomly selected cells revealed that the cromakalim-evoked changes in RMP and RN were highly significant (Table 1) . In order to test whether such a small hyperpolarization would be sufficient to account for the inhibitory action of cromakalim observed in the absence of TTX, the firing rate of 3 representative CA3 neurons was determined at RMP ( -64 mV to -66 mV) and during hyperpolarizations by 2 mV and 4 mV, respectively, using direct current (DC) injection ( Fig. 1 B, C) . The effects of such hyperpolarizations were comparable to the changes induced by 30 gmol/1 and 100 gmol/1 cromakalim, respec- Both curves intercept at a potential value 25 mV negative to the origin of the coordinate system. Since the origin corresponds to the RMP (--77 mV), in this neuron the equilibrium potential of the action of cromakalim was -102 mV tively (see Alzheimer and ten Bruggencate 1988; Fig. 5) . As shown by the ratemeter recording in Fig. 1 C, a hyperpolarization of the membrane potential by 4 mV was sufficient to suppress the spontaneous activity in CA3 neurons (cf. Hablitz and Johnston 1981) .
Effects of cromakalim on the I/V-relation
In order to study the cromakalim-induced conductance changes in more detail, I/V-relationships of CA3 pyramidal cells were determined by means of the switched currentclamp technique. Depolarizing and hyperpolarizing current pulses were injected and the corresponding voltage deviations were measured in the absence and presence of 100 gmol/1 cromakalim ( Fig. 2A, B) . Under control conditions (i.e. in the presence of TTX), the I/V-curve was nonlinear in all neurons tested (Fig. 2 C, closed circles) . In the depolarizing direction, the slope resistance (as determined from the slope of the curve) decreased with increasing current strength (outward rectification), whereas in the hyperpolarizing direction the curve was almost linear in a potential range 15-20 mV negative to the RMP. At current pulses with amplitudes larger than -0.4 nA, the slope resistance again decreased (inward rectification). Following the application of cromakalim (100 gmol/1), a negative shift of the I/V-curve along the voltage-axis was observed, corresponding to the drug-induced hyperpolarization of the RMP (Fig. 2C, open circles) . In addition, at every point of the curve there was a slight decrease in slope resistance which was clearly more pronounced in the hyperpolarizing direction as compared to the depolarizing direction. In order to quantify the difference, a rectification ratio (RR, see Connors et al. 1982) was calculated from the input resistances obtained by injection of depolarizing and hyperpolarizing current pulses (0.4 nA), respectively. Under control conditions, the RR was found to be 0.55 + 0.12 (n = 4), indicating outward rectification. In the same neurons, cromakalim produced a significant increase in the RR to 0.67 + 0.12 (paired t-test, p < 0.005). In all cases, the increase in RR was due to a significant decrease in the voltage changes produced by the hyperpolarizing current pulses, whereas voltage changes induced by the depolarizing current pulses remained constant or were only slightly decreased. This suggests that the decrease in the RR was the consequence of the activation of an inwardly rectifying conductance rather than the result of an inactivation of an outward rectifier.
In the hyperpolarizing direction, the I/V-curve obtained in the presence of cromakalim crossed the control curve in a potential range 20 -30 mV negative to the RMP (Fig. 2 C) . According to Ginsborg (1967) , this interception point indicates the reversal potential of the cromakalim-induced hyperpolarization; measurements in 6 neurons revealed a mean value of the cromakalim equilibrium potential of -100.3 + 3.8 mV. This value is similar to the Nernstian equilibrium potential for potassium ions under the exper-imental conditions used (assuming an intracellular potassium concentration of 120-150 raM, the EK ranged between -96 mV and -102 mV), suggesting that the cromakalim-induced hyperpolarization was due to the activation of a potassium conductance. To confirm this, cromakalim was applied at RMP (-67 _+ 2 mV, n = 4) and at a membrane potential of -100 mV obtained by hyperpolarizing DC injection. At RMP, cromakalim produced a mean hyperpolarization of 4.2 + 0.3 mV, whereas at -100 mV, the cromakalim-evoked hyperpolarization was found to be abolished or reversed (mean value: +0.25 _+ 0.4 mV), indicating a reversal potential close to -100 inV.
The results obtained under current clamp conditions suggested that cromakalim hyperpolarizes hippocampal CA3 neurons by activation of a voltage-dependent, inwardly rectifying potassium conductance. The possible voltage-dependence of the cromakalim-activated conductance was further investigated by determining the V/I-relationship of CA3 neurons using the single-electrode voltage-clamp technique. The neuronal membrane potential was clamped to a holding potential (Vn) of -70 mV. Depolarizing voltage steps (300-500 ms in duration) up to a command potential (Vc) of -30 mV elicited outward current responses (Fig. 3 A) , the amplitude of which remained unaltered in the presence of cromakalim (100 pmol/1, Fig. 3 A) . In contrast, when hyperpolarizing voltage steps were applied, a small but significant, cromakalim-induced increase in the amplitude of the inward current responses was observed in all neurons tested (n = 5, Fig. 3 B) . In the presence of cromakalim, the V/I-curve of these neurons revealed an increase in slope conductance at membrane potentials negative to Vn (Fig. 3C) . The observation that cromakalim enhanced the magnitude of the neurons' inward rectification in hyperpolarizing direction is in agreement with the results obtained under current clamp conditions and confirms our conclusion that cromakalim activates a voltage-dependent, inwardly rectifying potassium conductance.
Effects of potassium-channel blockers on the action of cromakalim
We used several potassium channel blockers to characterize the cromakalim-activated potassium conductance. In these experiments, the action of cromakalim (100 gmol/1) on the membrane potential and on the hyperpolarizing part of the I/V-curve was determined in the absence and presence of TEA (10-15mmol/1), 4-AP (0.1retool/I), tolbutamide (1 retool/l), intracellularly injected CsC1, extracellularly applied CsC1 (2 mmol/1), and BaC12 (0.1-0.5 mmol/1). In all neurons tested, neither TEA (n = 3) nor 4-AP (n = 3) nor intracellularly injected CsC1 (n=3) affected the cromakalim-evoked hyperpolarization or resistance decrease. Tolbutamide, a blocker of ATP-sensitive potassium channels in peripheral tissue (Trube et al. 1986 ), has been shown to antagonize the action of cromakalim in skeletal muscle (Spuler et al. 1989 ). Since ATP-sensitive potassium channels have been described in CNS neurons (Ashford et al. 1988) , we tested the effects of tolbutamide on the action of cromakalim on hippocampal CA3 neurons. Tolbutamide (1 mM) itself depolarized the membrane potential by 4.0+_1.0mV, and increased RN by 13.3_+3.3 MOhm (n = 3). However, the action of cromakalim on membrane potential and RN was not influenced by tolbutamide (n = 3). Upon addition of CsC1 (2 mmol/1) to a TTX-containing bathing medium an increase in RN by 40-50% without changes in RMP was observed in all neurons tested (n = 5). Measurements of the I/V-relationship in a potential range negative to the RMP revealed a Cs +-induced block of the hyperpolarizing inward rectification (Fig. 4A) . Under these conditions, cromakalim (100 gmol/1) neither affected the membrane potential nor the I/V-relationship in 3 out of 5 neurons investigated (Fig. 4A) . In the remaining two neurons, cromakalim produced membrane potential hyperpolarizations and decreases in RN, the magnitudes of which were somewhat smaller but not significantly different from the cromakalim-induced changes in the absence of Cs +, When added to a TTX-containing ACSF, Ba 2 + led to an increase in RN by 80 -100 %. This effect was accompanied by a slight depolarization of the membrane potential which we compensated for by hyperpolarizing DC-injection (0.01 -0.02 hA). Similar to Cs ÷, Ba 2 ÷ abolished or substan- In the presence of TTX (0.6 ~tmol/1) and 4-AP (0.1 mmol/1) a depolarizing current pulse (time of injection indicated by the arrow) evoked one calcium spike followed by a fast and slow afterhyperpolarization (control). The membrane potential was manually voltage-clamped to -7 0 mV (indicated by the upper dashed line). Upon application of cromakalim a slight increase in the amplitude and duration of the slow afterhyperpolarization could be observed. The lower dashed line indicates the maximal amplitude of the slow afterhyperpolarization in the presence of cromakalim tially reduced the hyperpolarizing inward rectification and blocked the action of cromakalim on the membrane potential and on the hyperpolarizing I/V-relation in all neurons tested (n = 4, Fig. 4 B) . In two cells, a partial recovery of the Ba 2 +-induced changes was observed following a prolonged washout. Simultaneously, the effects of cromakalim were found to partially recover. In 3 experiments, the slices were superfused with an ACSF containing TTX, Ba 2+ and Cs + (Fig. 4C) . Under these conditions, the hyperpolarizing I/V-relationship became steep and linear, and application of cromakalim was without any effect in all three neurons studied (Fig. 4C) .
Recent experiments in peripheral tissues have provided evidence for a facilitatory effect of cromakalim on the TEAinsensitive, Ca z +-activated potassium conductance (Nakao et al. 1988) . In central nervous system neurons, a similar potassium conductance has been demonstrated to be responsible for the slow afterhyperpolarization following a train of action potentials (Lancaster and Adams 1986) . In order to investigate the effects of cromakalim on the Ca 2 +-activated potassium conductance, the slices were perfused with a medium containing both TTX and 4-AP. Under these conditions, the injection of a depolarizing current pulse evoked a single calcium-dependent action potential followed by an afterhyperpolarization with constant amplitude and duration (Fig. 5, control) . Throughout the experiments, the membrane potential was manually voltage clamped to -7 0 mV. Upon application of cromakalim (100 gmol/1), a slight, statistically marginally significant (p < 0.08), increase in amplitude and duration of the afterhyperpolarization was observed in all neurons tested (n = 3, Fig. 5 ), suggesting that, in addition to its facilitatory action on anomalous rectifying potassium conductances, cromakalim might have a weak potentiating effect on the TEA-insensitive CaZ+-activated potassium conductance in guinea-pig hippocampal CA3 neurons.
Discussion
The present results on the action of cromakalim on guineapig hippocampal CA3 neurons obtained by means of intracellular recordings confirm and extend our observations made using extracellular recording techniques. As described in an earlier report (Alzheimer and ten Bruggencate 1988) , cromakalim inhibited the spontaneous spiking activity of CA3 neurons. In the absence of TTX, this cromakaliminduced inhibition occurred without an apparent change in membrane potential (see Alzheimer and ten Bruggencate 1988) . However, when spiking activity and spontaneous membrane potential oscillations were blocked by TTX, a cromakalim-induced hyperpolarization by 3-4 mV associated with a decrease in RN was unmasked. As demonstrated in Fig. 1 B and C, this small hyperpolarization per se is sufficient to account for the inhibitory effect of cromakalim on the spontaneous spiking activity of CA3 neurons. Furthermore, in contrast to membrane potential hyperpolarizations produced by DC injection, the cromakaliminduced hyperpolarization were accompanied by an increase in membrane conductance. Therefore, it can be assumed that the inhibitory efficacy of cromakalim-evoked hyperpolarizations is stronger than that of comparable hyperpolarizations caused by DC injections.
Although we did not perform a detailed analysis of the ionic mechanisms involved in the generation of the driving force for the cromakalim-induced hyperpolarization, our results strongly suggest that cromakalim hyperpolarizes the membrane of hippocampal CA3 neurons by activation of a potassium conductance. Measurements of I/V-relationships before and during drug application revealed that the corresponding curves intercept at membrane potential values 20-30 mV negative to the RMP. Such potentials were close to the EK calculated for the given experimental conditions (-96 mV to -102 mV). Furthermore, when the membrane potential was manually voltage-clamped to -100mV, cromakalim did not produce a hyperpolarization, but a slight depolarization of the membrane, indicating that the membrane potential was at, or slightly negative to, the equilibrium potential of the cromakalim-induced hyperpolarization. An involvement of chloride ions can be excluded, since all recordings were performed using electrodes filled with KC1 or CsC1. Leakage of chloride ions out of the electrodes led to a chloride equilibrium potential positive to the RMP, as revealed by depolarizing fast inhibitory postsynaptic potentials (data not shown).
In our first report on the action of cromakalim on CA3 neurons (Alzheimer and ten Bruggencate 1988), we observed that cromakalim was less effective at inhibiting spontaneous burst discharges in cells with RMP values slightly positive to the mean value of the total sample than in neurons with relatively high RMPs. This finding gave rise to the speculation that cromakalim might influence a voltage-dependent membrane conductance. The voltage-clamp experiments described in the present study show that cromakalim enhanced the membrane conductance at potentials negative to the mean RMP (-69.5 mV, see Table 1 ) without significantly affecting the conductance at potentials positive to the mean RMP (see Fig. 3 ). This is in agreement with the hypothesis that cromakalim activates or potentiates a voltage-dependent potassium conductance.
The investigation of the effects of well established blockers of potassium channels on the action of cromakalim provided further evidence that the compound influences the membrane properties by activation of voltage-dependent potassium conductances. While TEA, 4-AP, tolbutamide and internal Cs ÷ did not antagonize the drug's action, the cromakalim-induced changes in membrane potential and RN were found to be blocked in the presence of Cs + and/or Ba 2+. In different types of neurons, Cs ÷ has been shown to abolish anomalous rectification (hyperpolarizing inward rectification) by inactivating a voltage-dependent, mixed sodium-potassium-conductance (for review see Adams and Galvan 1986 ). In addition, Cs ÷ suppresses a fast activating inwardly rectifying potassium conductance demonstrated to be present in several types of central nervous system neurons (Constanti and Galvan 1983; Stanfield et al. 1985; Williams et al. 1988) . In contrast to Cs +, Ba z+ (100-500 pM) selectively blocks only the latter form of these inwardly rectifying conductances (Constanti and Galven 1983; Stanfield et al. 1985; Williams et al. 1988) . Our observation that both Cs + and Ba z+ reduced or suppressed anomalous rectification indicates the presence of similar inwardly rectifying potassium conductances in guinea-pig hippocampal CA3 neurons. Furthermore, since cromakalim was without effect when anomalous rectification was virtually abolished by the simultaneous application of Cs + and Ba 2+ (see Fig. 4C ), it is reasonable to conclude that cromakalim hyperpolarizes the membrane potential of hippocampal CA3 neurons by activation or potentiation of inwardly rectifying potassium conductances. An analogous action of cromakalim was described for guinea-pig isolated myocytes (Osterrieder 1988) . In these cells, the drug activated a Ba 2 + -sensitive, inwardly rectifying potassium conductance which resulted in a marked decrease in excitability. The concentrations necessary to evoke this effect (10-5-10 -4 mol/l) were similar to the concentrations necessary to induce inhibition in guinea-pig hippocampal CA3 neurons (3 x 10-5-10 .4 mol/1).
In addition to producing a hyperpolarization and a decrease in RN, cromakalim slightly enhanced the slow afterhyperpolarization following a single calcium-dependent action potential in hippocampal CA3 neurons (see Fig. 5 ). Since this afterhyperpolarization is most probably generated by the activation of a calcium-dependent potassium conductance (Lancaster and Adams 1986) , we assume that cromakalim has a weak facilitatory effect on this conductance. This would be in agreement with observations made in smooth muscle cells, where the cromakalim-induced potassium-dependent hyperpolarization has been demonstrated to be sensitive to the calcium channel blockers Mn z + and La 3 + (Nakao et al. 1988) .
In comparison to smooth muscle cells, where cromakalim at concentrations between 0.1 to 1 gmol/1 causes almost maximal increases in potassium conductance and marked changes in 86Rb+ efflux (Cook 1988) , cromakalim concentrations necessary to produce membrane hyperpolarizations, decreases in RN, and reductions in epileptiform activity in hippocampal CA3 neurons are relatively high (30-100 gmol/l). At the moment, there is no information about a cromakalim binding site or a "cromakalim-receptor". However, in order to produce its effect, cromakalim must bind either directly to the potassium channel protein or to another molecular structure which mediates the effect to the channel. The differences in the effective concentrations of cromakalim in smooth muscle preparations versus CNS preparations might be due to different binding sites with high and low affinity, or due to different effector systems, or both. The possibility that cromakalim acts as a weak agonist at a neurotransmitter receptor, the activation of which leads to an enhancement in anomalous rectification of CNS neurons, cannot be excluded. It has been demonstrated that 5-hydroxytryptamine (via the 5-HTl-receptor) and baclofen (via the GABAB-receptor) reduce the excitability of CNS neurons by the activation of an inwardly rectifying potassium conductance (Williams et al. 1988) .
